World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
54741
World Ranking
1138
National Ranking
603

Medicine

D-Index
88
Citations
54741
World Ranking
12889
National Ranking
6590

Kathleen M. Neuzil publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kathleen M. Neuzil sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 334 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kathleen M. Neuzil D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kathleen M. Neuzil sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2019 - Member of the National Academy of Medicine (NAM)

Overview

Kathleen M. Neuzil is affiliated with the University of Maryland, Baltimore in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in Infectious Diseases, Epidemiology, Health, Food Science, and Animal Science and Zoology.

Their work covers various topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • Viral gastroenteritis research and epidemiology
  • COVID-19 Clinical Research Studies
  • Vaccine Coverage and Hesitancy
  • Salmonella and Campylobacter epidemiology
  • Influenza Virus Research Studies
  • SARS-CoV-2 detection and testing

Kathleen M. Neuzil has published frequently in notable scientific venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • New England Journal of Medicine
  • Clinical Infectious Diseases
  • Vaccine
  • The Journal of Infectious Diseases

Their recent published papers include:

  • An mRNA Vaccine against SARS-CoV-2 - Preliminary Report, 2020, New England Journal of Medicine
  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates, 2020, New England Journal of Medicine
  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults, 2020, Nature
  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial, 2022, Science

The scientist has collaborated extensively with several frequent co-authors, including:

  • Lawrence Corey
  • Dean Follmann
  • Peter B. Gilbert
  • Hana M. El Sahly
  • Lindsey R. Baden

Kathleen M. Neuzil's work has been recognized through membership in the National Academy of Medicine since 2019.

Best Publications

  • Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

    Lindsey R. Baden;Hana M El Sahly;Brandon J Essink;Karen Kotloff

  • An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

    Lisa A. Jackson;Evan J. Anderson;Nadine G. Rouphael;Paul C. Roberts

  • A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

    M. N. Oxman;M. N. Oxman;M. J. Levin;G. R. Johnson;K. E. Schmader

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

    Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.

    Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

    Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

  • The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

    Kathleen Maletic Neuzil;Beverly G. Mellen;Peter F. Wright;Edward F. Mitchel

  • Effect of human rotavirus vaccine on severe diarrhea in African infants.

    Shabir A. Madhi;Nigel A. Cunliffe;Duncan Steele;Desirée Witte

  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.

    Peter B Gilbert;Peter B Gilbert;David C Montefiori;Adrian B McDermott;Youyi Fong

  • Impact of Influenza on Acute Cardiopulmonary Hospitalizations in Pregnant Women

    Kathleen Maletic Neuzil;George W. Reed;Edward F. Mitchel;Lone Simonsen

  • Homologous and Heterologous Covid-19 Booster Vaccinations

    Unknown

  • Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Scott A. Harper;John S. Bradley;Janet A. Englund;Thomas M. File

  • Effectiveness of pneumococcal polysaccharide vaccine in older adults.

    Lisa A. Jackson;Kathleen M. Neuzil;Onchee Yu;Patti Benson

  • Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

    Alicia T. Widge;Nadine G. Rouphael;Lisa A. Jackson;Evan J. Anderson

  • Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

    George E Armah;Samba O Sow;Robert F Breiman;Robert F Breiman;Michael J Dallas

  • The impact of vaccination on COVID-19 outbreaks in the United States.

    Seyed M Moghadas;Thomas N Vilches;Kevin Zhang;Chad R Wells

  • Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.

    Nicole Doria-Rose;Mehul S. Suthar;Mat Makowski;Sarah O’Connell

  • Burden of Interpandemic Influenza in Children Younger than 5 Years: A 25-Year Prospective Study

    Kathleen M. Neuzil;Yuwei Zhu;Marie R. Griffin;Kathryn M. Edwards

  • Influenza Vaccination of Pregnant Women and Protection of Their Infants

    Abstr Act;Shabir A. Madhi;Clare L. Cutland;Locadiah Kuwanda

  • Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

    Unknown

  • Evidence of bias in estimates of influenza vaccine effectiveness in seniors

    Lisa A Jackson;Michael L Jackson;Jennifer C Nelson;Kathleen M Neuzil

Frequent Co-Authors

Marie R. Griffin
Marie R. Griffin Vanderbilt University Medical Center
Shabir A. Madhi
Shabir A. Madhi University of the Witwatersrand
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Eric A. F. Simões
Eric A. F. Simões University of Colorado Denver
A. Duncan Steele
A. Duncan Steele Bill & Melinda Gates Foundation
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Janet A. Englund
Janet A. Englund Seattle Children's Hospital
Max Ciarlet
Max Ciarlet Novartis (Switzerland)
M. Elizabeth Halloran
M. Elizabeth Halloran Fred Hutchinson Cancer Research Center
David K. Shay
David K. Shay Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to diverse healthcare careers, including nursing and specialized practitioner roles. For those interested in nursing, exploring the easiest LPN programs to get into can provide a practical starting point. These programs offer accessible routes to gain foundational nursing skills, which complement immunological expertise in clinical settings.

Advancing further, nurse practitioner roles are highly sought after in immunology-related fields. Prospective students should consider the which nurse practitioner program is easiest to determine pathways that balance rigorous training with manageability. This can be crucial for busy professionals or those transitioning careers.

Specialized mental health nursing also ties closely to immunological health, particularly in psychiatric-immune interactions. The online pmhnp programs with clinical placement offer excellent clinical experiences vital for hands-on learning and career readiness.

Cost is another important factor. Those seeking affordable education options should explore the cheapest online pmhnp certificate programs to balance quality training with financial feasibility.

Best Scientists Citing Kathleen M. Neuzil

Trending Scientists

Recently Published Articles